The Joint Corp. (JYNT)
NASDAQ: JYNT · Real-Time Price · USD
8.14
-0.34 (-4.01%)
Oct 10, 2025, 1:28 PM EDT - Market open
The Joint Revenue
The Joint had revenue of $13.27M in the quarter ending June 30, 2025, a decrease of -56.15%. This brings the company's revenue in the last twelve months to $53.06M, up 10.56% year-over-year. In the year 2024, The Joint had annual revenue of $52.16M with 11.04% growth.
Revenue (ttm)
$53.06M
Revenue Growth
+10.56%
P/S Ratio
2.40
Revenue / Employee
$72,622
Employees
736
Market Cap
124.90M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 52.16M | 5.19M | 11.04% |
Dec 31, 2023 | 46.98M | -54.27M | -53.60% |
Dec 31, 2022 | 101.25M | 21.24M | 26.55% |
Dec 31, 2021 | 80.01M | 21.33M | 36.34% |
Dec 31, 2020 | 58.68M | 10.23M | 21.12% |
Dec 31, 2019 | 48.45M | 11.79M | 32.16% |
Dec 31, 2018 | 36.66M | 22.87M | 165.78% |
Dec 31, 2017 | 13.79M | 1.82M | 15.21% |
Dec 31, 2016 | 11.97M | 1.79M | 17.56% |
Dec 31, 2015 | 10.18M | 3.07M | 43.10% |
Dec 31, 2014 | 7.12M | 1.16M | 19.45% |
Dec 31, 2013 | 5.96M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
JYNT News
- 3 days ago - The Joint Chiropractic Continues Climb on the Franchise Times Top 400 List - PRNewsWire
- 7 days ago - The Joint Chiropractic Debuts in Delaware - PRNewsWire
- 9 days ago - The Joint Corp. Names Debbie L. Gonzalez Chief Marketing Officer - GlobeNewsWire
- 2 months ago - The Joint Corp. (JYNT) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - The Joint Corp. Expects to Restate Full Year 2024 and First Quarter 2025 Financial Statements due to Overestimated Noncash Impairment Charges - GlobeNewsWire
- 2 months ago - The Joint Corp. to Host Conference Call on Thursday, August 7th to Discuss Second Quarter 2025 Results - GlobeNewsWire
- 3 months ago - The Joint Corp. Closes Sale of 31 Corporate Clinics in Arizona and New Mexico and Acquires Regional Developer Rights in the Northwest Region - GlobeNewsWire
- 3 months ago - The Joint Chiropractic Launches Official Mobile App on iOS and Android - PRNewsWire